Inventor
KHANNA RICHIE
US14 patents
⚠️ This page may combine multiple inventors who share the name “KHANNA RICHIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMICUS THERAPEUTICS INC
13 patentsUS10357548B2Jul 23, 2019
α-galactosidase A and 1-deoxygalactonojirimycin co-formulation
AMICUS THERAPEUTICS INC49 citations95
US9694056B2Jul 4, 2017
α-galactosidase A and 1-deoxygalactonojirimycin co-formulation
AMICUS THERAPEUTICS INC50 citations94
US10155027B2Dec 18, 2018
Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease
AMICUS THERAPEUTICS INC49 citations92
US9303249B2Apr 5, 2016
High concentration α-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC15 citations92
US9404100B2Aug 2, 2016
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC16 citations90
US11278601B2Mar 22, 2022
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC5 citations83
US10857212B2Dec 8, 2020
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC7 citations83
US10512677B2Dec 24, 2019
High concentration alpha-glucosidase compositions for the treatment of pompe disease
AMICUS THERAPEUTICS INC4 citations83
US10046033B2Aug 14, 2018
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC4 citations83
US12419937B2Sep 23, 2025
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US12414985B2Sep 16, 2025
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US11278599B2Mar 22, 2022
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US12246062B2Mar 11, 2025
Recombinant human acid alpha-glucosidase
AMICUS THERAPEUTICS INC1 citations60